Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Sherman

Showing results (21-30 of 367) with videos related to

Pageof 37
Sort By:
Steroids|January 3, 2015
Relationships of sex steroid hormone levels in benign and cancerous breast tissue and blood: A critical appraisal of current scienceFrank Z Stanczyk, Brett W Mathews, Mark E Sherman
Endocrine Reviews|September 13, 2019
Progesterone and Breast CancerBritton Trabert, Mark E Sherman, Nagarajan Kannan, et al.
Gynecologic Oncology|December 5, 2008
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-scienceNicolas Wentzensen, Mark E Sherman, Mark Schiffman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2004
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinomaWilliam F Anderson, Kenneth C Chu, Shine Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Reply to m.j. Mourits et AlMark E Sherman, Marion Piedmonte, Phuong L Mai, et al.
Journal of the National Cancer Institute|February 5, 2015
The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescentsAimée R Kreimer, Mark E Sherman, Vikrant V Sahasrabuddhe, et al.
Cancer|February 5, 2005
Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survivalMark E Sherman, Sophia S Wang, Joseph Carreon, et al.
Cancer|December 23, 2006
The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytologyMark E Sherman, Abhijit Dasgupta, Mark Schiffman, et al.
The American Journal of Surgical Pathology|August 10, 2002
Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomasAnnette Staebler, Mark E Sherman, Richard J Zaino, et al.
Cancer|November 11, 2006
"Sip volume" as a quality indicator in liquid-based cervical cytologyMark E Sherman, Jessica Kahler, Karen S Gustafson, et al.
Pageof 37

Showing results (21-30 of 367) with videos related to

Sort By:
Pageof 37
Steroids|January 3, 2015
Relationships of sex steroid hormone levels in benign and cancerous breast tissue and blood: A critical appraisal of current scienceFrank Z Stanczyk, Brett W Mathews, Mark E Sherman
Endocrine Reviews|September 13, 2019
Progesterone and Breast CancerBritton Trabert, Mark E Sherman, Nagarajan Kannan, et al.
Gynecologic Oncology|December 5, 2008
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-scienceNicolas Wentzensen, Mark E Sherman, Mark Schiffman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2004
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinomaWilliam F Anderson, Kenneth C Chu, Shine Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Reply to m.j. Mourits et AlMark E Sherman, Marion Piedmonte, Phuong L Mai, et al.
Journal of the National Cancer Institute|February 5, 2015
The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescentsAimée R Kreimer, Mark E Sherman, Vikrant V Sahasrabuddhe, et al.
Cancer|February 5, 2005
Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survivalMark E Sherman, Sophia S Wang, Joseph Carreon, et al.
Cancer|December 23, 2006
The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytologyMark E Sherman, Abhijit Dasgupta, Mark Schiffman, et al.
The American Journal of Surgical Pathology|August 10, 2002
Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomasAnnette Staebler, Mark E Sherman, Richard J Zaino, et al.
Cancer|November 11, 2006
"Sip volume" as a quality indicator in liquid-based cervical cytologyMark E Sherman, Jessica Kahler, Karen S Gustafson, et al.
Pageof 37